While we are in wild speculation mode (to pass the time)...
What if:
They are having trouble kicking deals over the line because nobody is prepared to take the risk investing in a first to market new-technology from an unproven company (for example: safer to use inferior technology from an established technology provider than superior technology from a start-up. If things go tits-up you've got more chance of recovering from a big player like NVIDIA, IBM, INTEL, etc. and you won't lose your job for taking a punt).
So, one of their smaller customers has developed a winner (using Akida IP) but doesn't have the financial clout to bring it to market. BRN has decided to partner with them to make it happen - hence the cash-raise. If it is a game-changing technology that could really demonstrate the power of Akida then it would be a massive proof of concept and market validation. That would de-risk larger players adopting Akida.
How's that for pure speculation?
Or, it could just be a garden variety cash-raise to give them more runway.
- Forums
- ASX - By Stock
- BRN
- Ann: Trading Halt
Ann: Trading Halt, page-108
-
-
- There are more pages in this discussion • 101 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BRN (ASX) to my watchlist
|
|||||
Last
20.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $371.1M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5000 | 22.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
17.5¢ | 125000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5000 | 0.225 |
1 | 4545 | 0.220 |
1 | 7112 | 0.215 |
1 | 1 | 0.210 |
1 | 43 | 0.205 |
Price($) | Vol. | No. |
---|---|---|
0.175 | 125000 | 1 |
0.180 | 75000 | 1 |
0.190 | 5497 | 2 |
0.195 | 150000 | 3 |
0.200 | 241554 | 6 |
Last trade - 16.16pm 23/07/2024 (20 minute delay) ? |
Featured News
BRN (ASX) Chart |
Day chart unavailable
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & MD
Charles Armstrong
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online